Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) appears in 241 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 10,936 | 0.29% | $0.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 0 | 157,884 | 4.97% | $0.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 0 | 4,034 | 0.13% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -110,005 | -57.66% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 127,470 | 5.61% | $0.00 |
| Paradigm Biocapital Advisors LP | 31 Dec, 2025 | 0 | -103,544 | -3.88% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 1,455 | 130.96% | $0.00 |
| JENNISON ASSOCIATES LLC | 31 Dec, 2025 | 0 | -374,511 | -14.38% | $0.00 |
| Frazier Life Sciences Management, L.P. | 31 Dec, 2025 | 0 | -438,883 | -37.59% | $0.00 |
| Morgan Stanley | 31 Dec, 2025 | 0 | 128,340 | 6.71% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | -121,035 | -23.17% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 491,326 | 34.14% | $0.00 |
| MPM BioImpact LLC | 31 Dec, 2025 | 0 | -12,627 | -3.70% | $0.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | -1,266,173 | -51.58% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | -8,153 | -2.47% | $0.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | 141,386 | 13.71% | $0.00 |
| Integral Health Asset Management, LLC | 31 Dec, 2025 | 0 | -50,000 | -20.00% | $0.00 |
| Assenagon Asset Management S.A. | 31 Dec, 2025 | 0 | -120,224 | -9.63% | $0.00 |
| Russell Investments Group, Ltd. | 31 Dec, 2025 | 0 | 5,431 | 3.66% | $0.00 |
| Invesco Ltd. | 31 Dec, 2025 | 0 | 75,351 | 8.04% | $0.00 |